Naoko Takebe to Imatinib Mesylate
This is a "connection" page, showing publications Naoko Takebe has written about Imatinib Mesylate.
Connection Strength
0.148
-
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2015 Jun; 21(6):1083-90.
Score: 0.124
-
KIT as a therapeutic target in metastatic melanoma. JAMA. 2011 Jun 08; 305(22):2327-34.
Score: 0.024